Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Medulloblastoma 2Optic Nerve Glioma 1Glioma 1Familial ependymoma 1Central Nervous System Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Magnetic Resonance Spectroscopy 10Temozolomide 9X-Rays 7Specimen Handling 7Phantoms, Imaging 7Filgrastim 6Nuclear Medicine Department, Hospital 5Cyclophosphamide 5Carboplatin 5Vorinostat 4Thiotepa 4Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Irinotecan 4Cisplatin 4Biopsy 4tipifarnib 3O(6)-benzylguanine 3HhAntag691 3veliparib 2ulixertinib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2Vincristine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Medulloblastoma × RMP 7 × Clear all
NCT00019422 2013-08-16

Lobradimil and Carboplatin in Treating Children With Brain Tumors

National Cancer Institute (NCI)

Phase 2 Completed
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Central Nervous System Neoplasms, Optic Nerve Glioma

NCT00001502 2008-03-04

A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
30 enrolled
CNS

Brain Neoplasms, Glioma, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡